The World Health Organization said it will issue recommendations supporting a new class of near‑point‑of‑care molecular TB tests, adoption of tongue‑swab sampling, and pooled sputum testing to lower diagnostic costs and expand access. WHO plans an updated consolidated guideline and an operational toolkit to facilitate rollout, urging countries and partners to accelerate implementation to close diagnostic gaps. The guidance targets faster diagnosis of tuberculosis and rifampicin resistance by lowering instrument and per‑test costs and simplifying sample collection, particularly in settings with constrained lab infrastructure.